249 related articles for article (PubMed ID: 9033274)
1. Immunological evidence for hypochlorite-modified proteins in human kidney.
Malle E; Woenckhaus C; Waeg G; Esterbauer H; Gröne EF; Gröne HJ
Am J Pathol; 1997 Feb; 150(2):603-15. PubMed ID: 9033274
[TBL] [Abstract][Full Text] [Related]
2. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell LJ; Arnold L; Flowers D; Waeg G; Malle E; Stocker R
J Clin Invest; 1996 Mar; 97(6):1535-44. PubMed ID: 8617887
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
[TBL] [Abstract][Full Text] [Related]
4. Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium.
Porubsky S; Schmid H; Bonrouhi M; Kretzler M; Malle E; Nelson PJ; Gröne HJ
Am J Pathol; 2004 Jun; 164(6):2175-87. PubMed ID: 15161651
[TBL] [Abstract][Full Text] [Related]
5. Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol.
Malle E; Wäg G; Thiery J; Sattler W; Gröne HJ
Biochem Biophys Res Commun; 2001 Dec; 289(4):894-900. PubMed ID: 11735131
[TBL] [Abstract][Full Text] [Related]
6. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins.
Hazell LJ; Davies MJ; Stocker R
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584
[TBL] [Abstract][Full Text] [Related]
7. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies.
Malle E; Hazell L; Stocker R; Sattler W; Esterbauer H; Waeg G
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):982-9. PubMed ID: 7541296
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis.
Gröne HJ; Gröne EF; Malle E
Lab Invest; 2002 Jan; 82(1):5-14. PubMed ID: 11796821
[TBL] [Abstract][Full Text] [Related]
9. Hypochlorous acid and human blood low density lipoproteins modified by hypochlorous acid increase erythrocyte adhesion to endothelial cells.
Gorbatenkova EA; Artmann GM; Panasenko OM
Membr Cell Biol; 2000; 13(4):537-46. PubMed ID: 10926371
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase in kidney disease.
Malle E; Buch T; Grone HJ
Kidney Int; 2003 Dec; 64(6):1956-67. PubMed ID: 14633118
[TBL] [Abstract][Full Text] [Related]
11. Presence of LDL modified by myeloperoxidase in the penis in patients with vascular erectile dysfunction: a preliminary study.
Zouaoui Boudjeltia K; Roumeguere T; Delree P; Moguilevsky N; Ducobu J; Vanhaeverbeek M; Wespes E
Eur Urol; 2007 Jan; 51(1):262-8; discussion 268-9. PubMed ID: 17007997
[TBL] [Abstract][Full Text] [Related]
12. The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids.
Spickett CM; Jerlich A; Panasenko OM; Arnhold J; Pitt AR; Stelmaszyńska T; Schaur RJ
Acta Biochim Pol; 2000; 47(4):889-99. PubMed ID: 11996112
[TBL] [Abstract][Full Text] [Related]
13. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ
Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568
[TBL] [Abstract][Full Text] [Related]
14. Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
Van Antwerpen P; Legssyer I; Zouaoui Boudjeltia K; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
Eur J Pharmacol; 2006 May; 537(1-3):31-6. PubMed ID: 16631159
[TBL] [Abstract][Full Text] [Related]
15. Human neutrophils oxidize low-density lipoprotein by a hypochlorous acid-dependent mechanism: the role of vitamin C.
Carr AC; Frei B
Biol Chem; 2002; 383(3-4):627-36. PubMed ID: 12033452
[TBL] [Abstract][Full Text] [Related]
16. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G
J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363
[TBL] [Abstract][Full Text] [Related]
17. Effects of hypochlorite-modified low-density and high-density lipoproteins on intracellular Ca2+ and plasma membrane Ca(2+)-ATPase activity of human platelets.
Zabe M; Feltzer RE; Malle E; Sattler W; Dean WL
Cell Calcium; 1999 Dec; 26(6):281-7. PubMed ID: 10668566
[TBL] [Abstract][Full Text] [Related]
18. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
Sakata N; Moh A; Takebayashi S
Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
[TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide.
Sampson JB; Ye Y; Rosen H; Beckman JS
Arch Biochem Biophys; 1998 Aug; 356(2):207-13. PubMed ID: 9705211
[TBL] [Abstract][Full Text] [Related]
20. Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modification.
Kapiotis S; Jirovetz L; Hermann M; Laggner H; Exner M; Esterbauer H; Gmeiner BM
Biochimie; 2006 Jul; 88(7):785-91. PubMed ID: 16488068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
